Literature DB >> 21733245

Neuron density and serotonin receptor binding in prefrontal cortex in suicide.

Mark D Underwood1, Suham A Kassir, Mihran J Bakalian, Hanga Galfalvy, J John Mann, Victoria Arango.   

Abstract

Although serotonin receptor and cytoarchitectonic alterations are reported in prefrontal cortex (PFC) in suicide and depression, no study has considered binding relative to neuron density. Therefore, we measured neuron density and serotonin transporter (SERT), 5-HT1A and 5-HT2A binding in matched suicides and controls. Suicides and normal controls (n=15 matched pairs) were psychiatrically characterized. Neuron density and binding were determined in dorsal [Brodmann area (BA) 9] and ventral (BA 47) PFC by stereology and quantitative autoradiography in near-adjacent sections. Binding index was defined as the ratio of receptor binding to neuron density. Suicides had lower neuron density in the gyrus of both areas. The binding index was lower for SERT in BA 47 but not in BA9; the 5-HT1A binding index was higher in BA 9 but not in BA 47, while the 5-HT2A binding index was not different between groups. SERT binding was lower in suicides in BA 47 but not BA 9, while 5-HT1A binding was higher in BA 9 but not BA 47. SERT binding negatively correlated with 5-HT1A binding in BA 47 in suicides. Neuron density decreased with age. The 5-HT1A binding index was higher in females than males. We found lower neuron density and lower SERT binding index in both PFC regions in suicides. More 5-HT1A binding with less SERT binding and the negative correlation in depressed suicides suggests post-synaptic receptor up-regulation, and it is independent of the difference in neuron density. Thus, abnormalities in both cortical neurons and in their serotonergic innervation are present in suicides and future studies will need to determine whether cortical changes reflect the trophic effect of altered serotonin innervation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21733245      PMCID: PMC4167642          DOI: 10.1017/S1461145711000691

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  81 in total

1.  Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study.

Authors:  Ramin V Parsey; Maria A Oquendo; R Todd Ogden; Doreen M Olvet; Norman Simpson; Yung-Yu Huang; Ronald L Van Heertum; Victoria Arango; J John Mann
Journal:  Biol Psychiatry       Date:  2005-09-09       Impact factor: 13.382

2.  Antagonist but not agonist labeling of serotonin-1A receptors is decreased in major depressive disorder.

Authors:  Craig A Stockmeier; Eimear Howley; Xiaochun Shi; Anna Sobanska; Gerard Clarke; Lee Friedman; Grazyna Rajkowska
Journal:  J Psychiatr Res       Date:  2009-02-12       Impact factor: 4.791

3.  Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims.

Authors:  V Arango; M D Underwood; M Boldrini; H Tamir; S A Kassir; S Hsiung; J J Chen; J J Mann
Journal:  Neuropsychopharmacology       Date:  2001-12       Impact factor: 7.853

4.  Serotonin receptors in suicide victims with major depression.

Authors:  C A Stockmeier; G E Dilley; L A Shapiro; J C Overholser; P A Thompson; H Y Meltzer
Journal:  Neuropsychopharmacology       Date:  1997-02       Impact factor: 7.853

5.  5-hydroxytryptamine, noradrenaline, and dopamine in brainstem, hypothalamus, and caudate nucleus of controls and of patients committing suicide by coal-gas poisoning.

Authors:  C M Pare; D P Yeung; K Price; R S Stacey
Journal:  Lancet       Date:  1969-07-19       Impact factor: 79.321

6.  Neuroanatomic correlates of psychopathologic components of major depressive disorder.

Authors:  Matthew S Milak; Ramin V Parsey; John Keilp; Maria A Oquendo; Kevin M Malone; J John Mann
Journal:  Arch Gen Psychiatry       Date:  2005-04

7.  Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder.

Authors:  G Rajkowska; A Halaris; L D Selemon
Journal:  Biol Psychiatry       Date:  2001-05-01       Impact factor: 13.382

8.  Anterior cingulate cortex pathology in schizophrenia and bipolar disorder.

Authors:  C Bouras; E Kövari; P R Hof; B M Riederer; P Giannakopoulos
Journal:  Acta Neuropathol       Date:  2001-10       Impact factor: 17.088

9.  Detection of 5-hydroxytryptamine2 receptors by radioligand binding, northern blot analysis, and Ca2+ responses in rat primary astrocyte cultures.

Authors:  D C Deecher; B D Wilcox; V Dave; P A Rossman; H K Kimelberg
Journal:  J Neurosci Res       Date:  1993-06-15       Impact factor: 4.164

10.  Suicide and depression in the quantitative analysis of glutamic acid decarboxylase-Immunoreactive neuropil.

Authors:  Tomasz Gos; Karoline Günther; Hendrik Bielau; Henrik Dobrowolny; Christian Mawrin; Kurt Trübner; Ralf Brisch; Johann Steiner; Hans-Gert Bernstein; Zbigniew Jankowski; Bernhard Bogerts
Journal:  J Affect Disord       Date:  2008-06-06       Impact factor: 4.839

View more
  40 in total

1.  Length of axons expressing the serotonin transporter in orbitofrontal cortex is lower with age in depression.

Authors:  Grazyna Rajkowska; Gouri Mahajan; Beata Legutko; Lavanya Challagundla; Michael Griswold; Paul R Albert; Mireille Daigle; Jose J Miguel-Hidalgo; Mark C Austin; Randy D Blakely; David C Steffens; Craig A Stockmeier
Journal:  Neuroscience       Date:  2017-07-13       Impact factor: 3.590

2.  Differential effects of cannabinoid CB1 inverse agonists and antagonists on impulsivity in male Sprague Dawley rats: identification of a possibly clinically relevant vulnerability involving the serotonin 5HT1A receptor.

Authors:  Peter J McLaughlin; Julia E Jagielo-Miller; Emily S Plyler; Kerry K Schutte; V Kiran Vemuri; Alexandros Makriyannis
Journal:  Psychopharmacology (Berl)       Date:  2017-02-01       Impact factor: 4.530

Review 3.  Toward a biosignature for suicide.

Authors:  Maria A Oquendo; Gregory M Sullivan; Katherin Sudol; Enrique Baca-Garcia; Barbara H Stanley; M Elizabeth Sublette; J John Mann
Journal:  Am J Psychiatry       Date:  2014-10-31       Impact factor: 18.112

Review 4.  Endophenotypes as a measure of suicidality.

Authors:  Dimitry A Chistiakov; Zurab I Kekelidze; Vladimir P Chekhonin
Journal:  J Appl Genet       Date:  2012-09-02       Impact factor: 3.240

5.  5-HT1A receptor, 5-HT2A receptor and serotonin transporter binding in the human auditory cortex in depression

Authors:  Louisa J. Steinberg; Mark D. Underwood; Mihran J. Bakalian; Suham A. Kassir; J. John Mann; Victoria Arango
Journal:  J Psychiatry Neurosci       Date:  2019-09-01       Impact factor: 6.186

6.  Anxiety in major depression and cerebrospinal fluid free gamma-aminobutyric acid.

Authors:  J John Mann; Maria A Oquendo; Kalycia Trishana Watson; Maura Boldrini; Kevin M Malone; Steven P Ellis; Gregory Sullivan; Thomas B Cooper; Shan Xie; Dianne Currier
Journal:  Depress Anxiety       Date:  2014-05-27       Impact factor: 6.505

Review 7.  Transcriptional regulation of the 5-HT1A receptor: implications for mental illness.

Authors:  Paul R Albert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-09-05       Impact factor: 6.237

8.  Autoradiographic Evaluation of [(18)F]FECUMI-101, a High Affinity 5-HT1AR Ligand in Human Brain.

Authors:  J S Dileep Kumar; Mark D Underwood; Norman R Simpson; Suham A Kassir; Jaya Prabhakaran; Vattoly J Majo; Mihran J Bakalian; Ramin V Parsey; J John Mann; Victoria Arango
Journal:  ACS Med Chem Lett       Date:  2016-03-13       Impact factor: 4.345

Review 9.  Biological substrates underpinning diagnosis of major depression.

Authors:  Etienne Sibille; Beverly French
Journal:  Int J Neuropsychopharmacol       Date:  2013-05-14       Impact factor: 5.176

Review 10.  Monoamine-sensitive developmental periods impacting adult emotional and cognitive behaviors.

Authors:  Deepika Suri; Cátia M Teixeira; Martha K Caffrey Cagliostro; Darshini Mahadevia; Mark S Ansorge
Journal:  Neuropsychopharmacology       Date:  2014-09-02       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.